Insider Transactions in Q2 2022 at Albireo Pharma, Inc. (ALBO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
461
-1.0%
|
$8,759
$19.47 P/Share
|
|
Apr 25
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
312
-0.96%
|
$10,296
$33.42 P/Share
|
|
Apr 22
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
343
-1.03%
|
$11,319
$33.0 P/Share
|
|
Apr 22
2022
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
907
-1.59%
|
$29,931
$33.11 P/Share
|
|
Apr 22
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
103
-0.22%
|
$3,296
$32.92 P/Share
|
|
Apr 22
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
103
-0.3%
|
$3,296
$32.92 P/Share
|
|
Apr 22
2022
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
103
-0.39%
|
$3,296
$32.92 P/Share
|
|
Apr 22
2022
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
200
-0.34%
|
$6,400
$32.92 P/Share
|
|
Apr 22
2022
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
103
-0.65%
|
$3,296
$32.92 P/Share
|
|
Apr 11
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
96
-0.28%
|
$3,360
$35.74 P/Share
|